Metabolic cardiomyopathy in pediatrics.
Tril VE, Burlutskaya AV, Polischuk LV.
Rev Cardiovasc Med. 2019 Jun 30;20(2):73-80. doi: 10.31083/j.rcm.2019.02.5151.
Inflammation and metabolic cardiomyopathy.
Nishida K, Otsu K.
Cardiovasc Res. 2017 Mar 15;113(4):389-398. doi: 10.1093/cvr/cvx012.
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy.
Chen Z, Jin ZX, Cai J, Li R, Deng KQ, Ji YX, Lei F, Li HP, Lu Z, Li H.
J Mol Med (Berl). 2022 Dec;100(12):1721-1739. doi: 10.1007/s00109-022-02269-1. Epub 2022 Nov 17.
Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy.
Peterson LR, Gropler RJ.
Circ Res. 2020 May 22;126(11):1628-1645. doi: 10.1161/CIRCRESAHA.120.315899. Epub 2020 May 21.
Heart Metabolism in Sepsis-Induced Cardiomyopathy-Unusual Metabolic Dysfunction of the Heart.
Wasyluk W, Nowicka-Stążka P, Zwolak A.
Int J Environ Res Public Health. 2021 Jul 16;18(14):7598. doi: 10.3390/ijerph18147598.
Metabolic dysfunction in diabetic cardiomyopathy.
Isfort M, Stevens SC, Schaffer S, Jong CJ, Wold LE.
Heart Fail Rev. 2014 Jan;19(1):35-48. doi: 10.1007/s10741-013-9377-8.
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.
Peng ML, Fu Y, Wu CW, Zhang Y, Ren H, Zhou SS.
Front Endocrinol (Lausanne). 2022 Jun 15;13:907757. doi: 10.3389/fendo.2022.907757. eCollection 2022.
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
Meyers DE, Basha HI, Koenig MK.
Tex Heart Inst J. 2013;40(4):385-94.
Diabetic cardiomyopathy: a metabolic perspective.
Avogaro A, Vigili de Kreutzenberg S, Negut C, Tiengo A, Scognamiglio R.
Am J Cardiol. 2004 Apr 22;93(8A):13A-16A. doi: 10.1016/j.amjcard.2003.11.003.
Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy.
Kuroshima T, Kawaguchi S, Okada M.
Int J Mol Sci. 2024 Apr 26;25(9):4710. doi: 10.3390/ijms25094710.
